Chemogenomics of Sensitivity and Resistance to Anticancer Drugs

Publisher： Bentham Science Publishers

E-ISSN： 1875-6204|5|1|11-19

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.5, Iss.1, 2007-03, pp. : 11-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anticancer Alkylphospholipids: Mechanisms of Action, Cellular Sensitivity and Resistance, and Clinical Prospects

By  

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2061-2074

Bentham Science Publishers

Access to resources Recommend Favorite

Multidrug resistance (MDR) in cancer - Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs

By Krishna R.   Mayer L.D.  

European Journal of Pharmaceutical Sciences, Vol. 11, Iss. 4, 2000-10 ,pp. : 265-283

Elsevier

Access to resources Recommend Favorite

Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2

By Lepper Erin R   Nooter Kees   Verweij Jaap   Acharya Milin R   Figg William D   Sparreboom Alex  

Pharmacogenomics, Vol. 6, Iss. 2, 2005-03 ,pp. : 115-138

Future Medicine

Access to resources Recommend Favorite

Individualized Treatment Planning in Oncology: Role of PET and Radiolabelled Anticancer Drugs in Predicting Tumour Resistance

By  

Current Pharmaceutical Design, Vol. 14, Iss. 28, 2008-10 ,pp. : 2914-2931

Bentham Science Publishers

Access to resources Recommend Favorite

Possible Effects of Early Treatments of Hsp90 Inhibitors on Preventing the Evolution of Drug Resistance to Other Anti-Cancer Drugs

By  

Current Medicinal Chemistry, Vol. 14, Iss. 2, 2007-01 ,pp. : 223-232

Bentham Science Publishers

Access to resources Recommend Favorite